320 related articles for article (PubMed ID: 27817236)
1. [Incidence of hepatocellular carcinoma and consequent lessons for its management in Northeastern Hungary].
Papp R; Papp M; Tornai I; Vitális Z
Orv Hetil; 2016 Nov; 157(45):1793-1801. PubMed ID: 27817236
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
[TBL] [Abstract][Full Text] [Related]
3. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
6. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and treatment of hepatocellular carcinoma.
Hartke J; Johnson M; Ghabril M
Semin Diagn Pathol; 2017 Mar; 34(2):153-159. PubMed ID: 28108047
[TBL] [Abstract][Full Text] [Related]
8. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
Yopp AC; Choti MA
Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
[TBL] [Abstract][Full Text] [Related]
9. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation.
Schöniger-Hekele M; Müller C; Kutilek M; Oesterreicher C; Ferenci P; Gangl A
Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):941-8. PubMed ID: 10958223
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus: the burden of the disease.
Adler M; Goubau P; Nevens F; Van Vlierberghe H
Acta Gastroenterol Belg; 2002; 65(2):83-6. PubMed ID: 12148444
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.
Stuart KE; Anand AJ; Jenkins RL
Cancer; 1996 Jun; 77(11):2217-22. PubMed ID: 8635087
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of hepatitis C].
Thies P; Schmid RM; Geisler F
MMW Fortschr Med; 2012 Nov; 154(19):59-62. PubMed ID: 23173289
[No Abstract] [Full Text] [Related]
14. Epidemiology, disease burden and outcomes of cirrhosis in a large secondary care hospital in South Auckland, New Zealand.
Hsiang JC; Bai WW; Raos Z; Stableforth W; Upton A; Selvaratnam S; Gane EJ; Gerred SJ
Intern Med J; 2015 Feb; 45(2):160-9. PubMed ID: 25371019
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
[TBL] [Abstract][Full Text] [Related]
16. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
17. Screening for hepatocellular carcinoma in cirrhosis.
Bolondi L
J Hepatol; 2003 Dec; 39(6):1076-84. PubMed ID: 14642630
[No Abstract] [Full Text] [Related]
18. Imaging evaluation of hepatocellular carcinoma.
Kamel IR; Bluemke DA
J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S173-84. PubMed ID: 12354834
[TBL] [Abstract][Full Text] [Related]
19. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
20. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
